NewsFeed Voices Science Insight Innovation
November, 2025
November 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
Marilena Vrana: Europe’s Plasma Supply Chain is at a Critical Juncture, and Current Policies are not Equipped to Fix it
Marilena Vrana/LinkedIn
Oct 5, 2025, 11:50

Marilena Vrana: Europe’s Plasma Supply Chain is at a Critical Juncture, and Current Policies are not Equipped to Fix it

Marilena Vrana, Vice President at the Plasma Protein Therapeutics Association (PPTA) Europe, shared a post on LinkedIn:

“Europe’s plasma supply chain is at a critical juncture, and current policies are not equipped to fix it.

In my latest opinion piece The Brussels Times, I break down why plasma-derived medicines require a holistic policy approach – especially as the Critical Medicines Act takes shape.

  • Europe’s dependence on US plasma
  • Why PDMPs don’t fit policies designed to tackle supply chains of chemically synthesized pharmaceuticals
  • The pitfalls of “one-size-fits-all” approach
  • The importance of collaboration

If we, Europeans, aim to achieve strategic autonomy and security of medicines supply, our policies must be grounded in reality.

International Plasma Awareness Week, which starts on October 6th, offers the perfect moment to reset Europe’s approach.”

Marilena Vrana: Europe’s Plasma Supply Chain is at a Critical Juncture, and Current Policies are not Equipped to Fix it

Read more here.

Stay updated with Hemostasis Today.

Critical Juncture Europe’s Plasma Supply Chain Health Hematology Hemostasis Hemostasis Today International Plasma Awareness week Marilena Vrana Medicine The Brussels Times
NewsFeed